Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage
AH Talal,
EO Dumas,
B Bauer,
RM Rejman,
A Ocque,
GD Morse,
D Lucic,
G Cloherty,
J King,
J Zha,
H Zhang,
DE Cohen,
NS Shulman,
Jean-Michel PAWLOTSKY,
Christophe HEZODE,
J Infect Dis 17/01/2018;217(3) : 474-482 10.1093/infdis/jix495.
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
AD Marshall,
EB Cunningham,
S Nielsen,
A Aghemo,
H Alho,
M Backmund,
P Bruggmann,
O Dalgard,
C Seguin-Devaux,
R Flisiak,
GR Foster,
L Gheorge,
D Goldberg,
I Goulis,
M Hickman,
P Hoffmann,
L Janconriene,
P Jarcuska,
M Kaberg,
LG Kostrikis,
M Makara,
M Maimets,
RT Marinho,
M Maticic,
S Norris,
S Olafsson,
A Ovrehus,
Jean-Michel PAWLOTSKY,
J Pocock,
G Robayes,
C Roncero,
M Simonova,
J Sperl,
M Tait,
I Tolmane,
S Tomaselli,
M van der Valk,
A Vince,
GJ Dore,
JV Lazarus,
J Grebely,
International Network on Hepatitis in Substance Users (INHSU)
Lancet Gastroenterol Hepatol. 27/11/2017;pii: S2468-1253(17) : 30284-4 0.1016/S2468-1253(17)30284-4. 27/11/2017
Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania
Z Mohamed,
J Mbwambo,
Y Shimakawa,
Lila POITEAU,
Stephane CHEVALIEZ,
Jean-Michel PAWLOTSKY,
J Rwegasha,
S Bhagani,
SD Taylor-Robinson,
J Makani,
MR Thursz,
M Lemoine,
j Int AIDS Soc. 19/09/2017;20(1) : 21856 10.7448/IAS.20.1.21856.
Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice
H Lerat,
MR Imache,
J Polyte,
A Gaudin,
M Mercey,
F Donati,
Camille BAUDESSON,
MR Higgs,
A Picard,
C Magnan,
F Foufelle,
Jean-Michel PAWLOTSKY,
J Biol Chem. 04/08/2017;292(31) : 12860-12873 10.1074/jbc.M117.785030. 30/05/2017
